{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:57:37Z","timestamp":1792627057731,"version":"4.5.0"},"publisher-location":"New York, NY","reference-count":21,"publisher":"Springer US","isbn-type":[{"value":"9781071648063","type":"print"},{"value":"9781071648070","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:00:00Z","timestamp":1763856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:00:00Z","timestamp":1763856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-4807-0_18","type":"book-chapter","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T09:27:53Z","timestamp":1763803673000},"page":"215-225","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development of a Gene Therapy with Lentiviral Vectors for Spinocerebellar Ataxias"],"prefix":"10.1007","author":[{"given":"Tiago","family":"Moreira-Gomes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9vio","family":"N\u00f3brega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,23]]},"reference":[{"key":"18_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3721","volume":"26","author":"SL Ginn","year":"2024","unstructured":"Ginn SL, Mandwie M, Alexander IE, Edelstein M, Abedi MR (2024) Gene therapy clinical trials worldwide to 2023\u2014an update. J Gene Med 26:e3721. https:\/\/doi.org\/10.1002\/jgm.3721","journal-title":"J Gene Med"},{"key":"18_CR2","unstructured":"FDA (2020) Long term follow-up after Administration of Human Gene Therapy Products; Guidance for Industry"},{"key":"18_CR3","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12951-023-02044-5","volume":"21","author":"C Wang","year":"2023","unstructured":"Wang C, Pan C, Yong H, Wang F, Bo T, Zhao Y, Ma B, He W, Li M (2023) Emerging non-viral vectors for gene delivery. J Nanobiotechnol 21:272. https:\/\/doi.org\/10.1186\/s12951-023-02044-5","journal-title":"J Nanobiotechnol"},{"key":"18_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-41333-0","volume-title":"A handbook of gene and Cell therapy","author":"C N\u00f3brega","year":"2020","unstructured":"N\u00f3brega C, Mendon\u00e7a L, Matos CA (2020) A handbook of gene and Cell therapy. Springer, Cham"},{"key":"18_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2015.35","volume":"1","author":"SG Deeks","year":"2015","unstructured":"Deeks SG, Overbaugh J, Phillips A, Buchbinder S (2015) HIV infection. Nat Rev Dis Primer 1:1\u201322. https:\/\/doi.org\/10.1038\/nrdp.2015.35","journal-title":"Nat Rev Dis Primer"},{"key":"18_CR6","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nature08237","volume":"460","author":"JM Watts","year":"2009","unstructured":"Watts JM, Dang KK, Gorelick RJ, Leonard CW, Bess JW Jr, Swanstrom R, Burch CL, Weeks KM (2009) Architecture and secondary structure of an entire HIV-1 RNA genome. Nature 460:711\u2013716. https:\/\/doi.org\/10.1038\/nature08237","journal-title":"Nature"},{"key":"18_CR7","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nrg1066","volume":"4","author":"CE Thomas","year":"2003","unstructured":"Thomas CE, Ehrhardt A, Kay MA (2003) Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 4:346\u2013358. https:\/\/doi.org\/10.1038\/nrg1066","journal-title":"Nat Rev Genet"},{"key":"18_CR8","first-page":"1","volume-title":"Viral vectors for gene therapy: methods and protocols","author":"JN Warnock","year":"2011","unstructured":"Warnock JN, Daigre C, Al-Rubeai M (2011) Introduction to viral vectors. In: Merten O-W, Al-Rubeai M (eds) Viral vectors for gene therapy: methods and protocols. Humana Press, Totowa, pp 1\u201325"},{"key":"18_CR9","doi-asserted-by":"publisher","first-page":"dmm050623","DOI":"10.1242\/dmm.050623","volume":"17","author":"TA Fox","year":"2024","unstructured":"Fox TA, Booth C (2024) Improving access to gene therapy for rare diseases. Dis Model Mech 17:dmm050623. https:\/\/doi.org\/10.1242\/dmm.050623","journal-title":"Dis Model Mech"},{"key":"18_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-019-0074-3","volume":"5","author":"T Klockgether","year":"2019","unstructured":"Klockgether T, Mariotti C, Paulson HL (2019) Spinocerebellar ataxia. Nat Rev Dis Primer 5:1\u201321. https:\/\/doi.org\/10.1038\/s41572-019-0074-3","journal-title":"Nat Rev Dis Primer"},{"key":"18_CR11","first-page":"143","volume-title":"Handbook of clinical neurology","author":"CA Stoyas","year":"2018","unstructured":"Stoyas CA, La Spada AR (2018) Chapter 11 \u2013 the CAG\u2013polyglutamine repeat diseases: a clinical, molecular, genetic, and pathophysiologic nosology. In: Geschwind DH, Paulson HL, Klein C (eds) Handbook of clinical neurology. Elsevier, pp 143\u2013170"},{"key":"18_CR12","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.3390\/ijms22084249","volume":"22","author":"R Afonso-Reis","year":"2021","unstructured":"Afonso-Reis R, Afonso IT, N\u00f3brega C (2021) Current status of gene therapy research in Polyglutamine spinocerebellar ataxias. Int J Mol Sci 22:4249. https:\/\/doi.org\/10.3390\/ijms22084249","journal-title":"Int J Mol Sci"},{"key":"18_CR13","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1111\/jnc.16010","volume":"168","author":"T Moreira-Gomes","year":"2024","unstructured":"Moreira-Gomes T, N\u00f3brega C (2024) From the disruption of RNA metabolism to the targeting of RNA-binding proteins: the case of polyglutamine spinocerebellar ataxias. J Neurochem 168:1442\u20131459. https:\/\/doi.org\/10.1111\/jnc.16010","journal-title":"J Neurochem"},{"key":"18_CR14","doi-asserted-by":"publisher","first-page":"16017","DOI":"10.1038\/mtm.2016.17","volume":"3","author":"O-W Merten","year":"2016","unstructured":"Merten O-W, Hebben M, Bovolenta C (2016) Production of lentiviral vectors. Mol Ther Methods Clin Dev 3:16017. https:\/\/doi.org\/10.1038\/mtm.2016.17","journal-title":"Mol Ther Methods Clin Dev"},{"key":"18_CR15","doi-asserted-by":"publisher","unstructured":"Koppenol R, Concei\u00e7\u00e3o A, Afonso IT, Afonso-Reis R, Costa RG, Tom\u00e9 S, Teixeira D, da Silva JP, C\u00f4desso J-M, Brito DVC, Mendon\u00e7a L, Marcelo A, Pereira de Almeida L, Matos CA, N\u00f3brega C (2022) The stress granule protein G3BP1 alleviates spinocerebellar ataxia-associated deficits. Brain. J Neurol awac473. https:\/\/doi.org\/10.1093\/brain\/awac473","DOI":"10.1093\/brain\/awac473"},{"key":"18_CR16","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1460-9568.2006.04927.x","volume":"24","author":"T Torashima","year":"2006","unstructured":"Torashima T, Yamada N, Itoh M, Yamamoto A, Hirai H (2006) Exposure of lentiviral vectors to subneutral pH shifts the tropism from Purkinje cell to Bergmann glia. Eur J Neurosci 24:371\u2013380. https:\/\/doi.org\/10.1111\/j.1460-9568.2006.04927.x","journal-title":"Eur J Neurosci"},{"key":"18_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/mt.2011.204","volume":"20","author":"W Xu","year":"2012","unstructured":"Xu W, Russ JL, Eiden MV (2012) Evaluation of residual promoter activity in \u03b3-retroviral self-inactivating (SIN) vectors. Mol Ther 20:84\u201390. https:\/\/doi.org\/10.1038\/mt.2011.204","journal-title":"Mol Ther"},{"key":"18_CR18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12311-008-0012-5","volume":"7","author":"H Hirai","year":"2008","unstructured":"Hirai H (2008) Progress in transduction of cerebellar Purkinje cells in vivo using viral vectors. Cerebellum 7:273\u2013278. https:\/\/doi.org\/10.1007\/s12311-008-0012-5","journal-title":"Cerebellum"},{"key":"18_CR19","volume-title":"Effects of storage conditions on the morphology and titer of Lentiviral vectors","author":"H Rahman","year":"2013","unstructured":"Rahman H, Taylor J, Clack B, Stewart R, Canterberry S (2013) Effects of storage conditions on the morphology and titer of Lentiviral vectors. Fac Publ"},{"key":"18_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1472-6750-6-34","volume":"6","author":"M Geraerts","year":"2006","unstructured":"Geraerts M, Willems S, Baekelandt V, Debyser Z, Gijsbers R (2006) Comparison of lentiviral vector titration methods. BMC Biotechnol 6:34. https:\/\/doi.org\/10.1186\/1472-6750-6-34","journal-title":"BMC Biotechnol"},{"key":"18_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/978-1-62703-444-9_12","volume-title":"Neural development: methods and protocols","author":"B Ding","year":"2013","unstructured":"Ding B, Kilpatrick DL (2013) Lentiviral vector production, titration, and transduction of primary neurons. In: Zhou R, Mei L (eds) Neural development: methods and protocols. Humana Press, Totowa, NJ, pp 119\u2013131"}],"container-title":["Methods in Molecular Biology","Lentiviral Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4807-0_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T15:58:04Z","timestamp":1779551884000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4807-0_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,23]]},"ISBN":["9781071648063","9781071648070"],"references-count":21,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4807-0_18","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,23]]},"assertion":[{"value":"23 November 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}